United States Diagnostic Radiopharmaceutical Market Report: Growing Demand Across Hospitals and Nuclear Medicine Centers
The US diagnostic radiopharmaceutical market represents a significant portion of North America's overall demand. The country benefits from a well-developed healthcare system, extensive availability of PET and SPECT imaging facilities, and strong research and development capabilities in nuclear medicine. Increasing cancer incidence and the growing clinical use of molecular imaging are creating sustained demand for diagnostic radiopharmaceuticals.
Read More - https://www.theinsightpartners.....com/reports/diagnos
Like
Comment
Share
